Glad to share our review article from talented @LiangliangJi and coauthors @NatRevImmunol on the fascinating topic of monocytes and macrophages in cancer. Understanding their contextual roles across primary and metastatic tumors shall guild their therapeutic targeting.
Excited to share our new paper led by @mattabolite in collaboration with Saharon Rosset showing that the Warburg Effect is the result of faster ATP production by glycolysis than respiration. A 🧵... 1/n https://t.co/m32QAaK4i0
Glad to share our review article @AnnualReviews on tissue-resident innate and adaptive lymphocytes in cancer. Defining their identities and sensing mechanisms shall guide targeting such prewired and priming-dependent defense responses for cancer therapies. https://t.co/pg5DmGsLcN
28 cancers are now treatable with immunotherapy, thanks to the work of the Cancer Research Institute. Explore our Impact Report, and discover how CRI is transforming the lives of cancer patients on a global scale: https://t.co/AD6s5fn0F8 #CancerResearch#Immunotherapy
MSK's Dr. Ming Li (@MingLiLab) discusses how his lab is working to harness the power of the immune system against #cancer — including a new paper just out in @ImmunityCP. https://t.co/ip85BZJJSh
@XuZhouLab Thanks, Xu! This is another example of heterocellular competition in addition to competition between TAMs and cancer cells in the Myc-PyMT model
Reprogram tumor-associated macrophages to outcompete endothelial progenitor cells and suppress tumor neoangiogenesis. Excited to share our new study @ImmunityCP by brilliant @miahdo1 , Wei Shi, and @CancerResearch fellow @LiangliangJi and collaborators!